The inhibition of COX-1 results in some undesirable side-effects, whereas COX-2 inhibition provides therapeutic effects in pain, inflammation, cancer, glaucoma, and Alzheimer’s and Parkinson disease [20]. This evidence concerns the gene PTGS1 and Parkinson disease.